Crescent Capital Bdc, Inc. (FCRX) — SEC Filings

Crescent Capital Bdc, Inc. (FCRX) — 23 SEC filings. Latest: 10-Q (Nov 12, 2025). Includes 8 8-K, 6 10-Q, 2 DEF 14A.

View Crescent Capital Bdc, Inc. on SEC EDGAR

Overview

Crescent Capital Bdc, Inc. (FCRX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 12, 2025: Crescent Capital BDC, Inc. (FCRX) reported a significant decline in net investment income for the nine months ended September 30, 2025, falling to $50.437 million from $68.560 million in the prior year, a decrease of 26.4%. Total investment income also decreased by 16.3%, from $150.945 million in 20

Sentiment Summary

Across 23 filings, the sentiment breakdown is: 2 bearish, 21 neutral. The dominant filing sentiment for Crescent Capital Bdc, Inc. is neutral.

Filing Type Overview

Crescent Capital Bdc, Inc. (FCRX) has filed 6 10-Q, 8 8-K, 2 DEF 14A, 2 10-K, 2 SC 13G, 1 8-K/A, 2 SC 13G/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (23)

Crescent Capital Bdc, Inc. SEC Filing History
DateFormDescriptionRisk
Nov 12, 202510-QCrescent Capital BDC's Net Investment Income Plunges 26% YOYhigh
Nov 3, 20258-K8-K Filing
Aug 13, 202510-QFCRX Net Investment Income Plunges 25% Amidst Realized Losseshigh
May 19, 20258-KCrescent Capital BDC Reports Shareholder Vote Matterslow
May 14, 202510-Q10-Q Filing
Apr 15, 20258-KCrescent Capital BDC Files 8-K for Material Agreementmedium
Mar 28, 2025DEF 14ACrescent Capital BDC Files Definitive Proxy Statementlow
Feb 19, 202510-K10-K Filing
Dec 23, 20248-KCrescent Capital BDC Enters Material Agreementmedium
Dec 6, 20248-KCrescent Capital BDC Files 8-K on Material Agreementlow
Nov 26, 2024SC 13GSC 13G Filing
Nov 12, 202410-QCrescent Capital BDC, Inc. Files Q3 2024 10-Qlow
Aug 12, 202410-Q10-Q Filing
Jun 17, 20248-K/ACrescent Capital BDC Files 8-K/A Amendmentlow
Jun 11, 20248-KCrescent Capital BDC Files 8-K for Regulation FD Disclosurelow
Jun 4, 20248-KCrescent Capital BDC Files 8-K for Material Agreementlow
May 15, 20248-KCrescent Capital BDC Files 8-K on Shareholder Voteslow
May 8, 202410-QCrescent Capital BDC, Inc. Q1 2024 10-Q Filinglow
Apr 10, 2024SC 13G/ASC 13G/A Filing
Mar 26, 2024DEF 14ACrescent Capital BDC, Inc. Announces 2024 Annual Meeting of Stockholderslow

Risk Profile

Risk Assessment: Of FCRX's 15 recent filings, 2 were flagged as high-risk, 3 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Crescent Capital Bdc, Inc. Financial Summary (10-Q, Nov 12, 2025)
MetricValue
Revenue$126.473M
Net Income($26.562M)
EPSN/A
Debt-to-EquityN/A
Cash PositionN/A
Operating MarginN/A
Total AssetsN/A
Total DebtN/A

Industry Context

Business Development Companies (BDCs) like Crescent Capital operate in the specialized finance sector, providing debt and equity capital to middle-market companies. The industry is sensitive to interest rate movements, credit market conditions, and overall economic health. Competition for attractive investment opportunities remains a key factor, influencing deal sourcing and yield potential.

Top Tags

BDC (4) · material-agreement (4) · disclosure (3) · Investment Income (2) · Net Asset Value (2) · Financial Performance (2) · shareholder-vote (2) · corporate-governance (2) · filing (2) · 10-Q (2)

Key Numbers

Crescent Capital Bdc, Inc. Key Metrics
MetricValueContext
Net Investment Income (9M 2025)$50.437MDecreased from $68.560M in 9M 2024, a 26.4% decline.
Total Investment Income (9M 2025)$126.473MDecreased from $150.945M in 9M 2024, a 16.3% decline.
Net Asset Value per Share (Sept 30, 2025)$19.28Decreased from $19.98 as of Dec 31, 2024.
Net Decrease in Net Assets from Operations (9M 2025)($26.562M)A significant reversal from a $6.213M increase in 9M 2024.
Net Realized Loss on Investments (9M 2025)($14.413M)Increased from ($463K) in 9M 2024.
Net Change in Unrealized Appreciation on Controlled Investments (9M 2025)$7.527MImproved from ($15.231M) depreciation in 9M 2024.
Common Shares Outstanding (Sept 30, 2025)37,039,657Slightly decreased from 37,061,547 shares as of Dec 31, 2024 due to repurchases.
Net Investment Income$33.51MDecreased by 25.57% from $45.02M for the six months ended June 30, 2024
Total Investment Income$85.12MDecreased by 14.3% from $99.31M for the six months ended June 30, 2024
Net Asset Value per Share$19.55Decreased from $19.98 at December 31, 2024
Net decrease in net assets from operations$15.92MFor the six months ended June 30, 2025, compared to a $9.85M increase in 2024
Debt (net)$887.32MIncreased from $875.84M at December 31, 2024
Interest income from non-controlled non-affiliated investments$73.16MDecreased from $85.54M for the six months ended June 30, 2024
Net realized loss on controlled investments$3.80MFor the six months ended June 30, 2025
Common shares outstanding37,061,547As of August 13, 2025

Related Companies

CCAP

Frequently Asked Questions

What are the latest SEC filings for Crescent Capital Bdc, Inc. (FCRX)?

Crescent Capital Bdc, Inc. has 23 recent SEC filings from Jan 2024 to Nov 2025, including 8 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of FCRX filings?

Across 23 filings, the sentiment breakdown is: 2 bearish, 21 neutral. The dominant sentiment is neutral.

Where can I find Crescent Capital Bdc, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Crescent Capital Bdc, Inc. (FCRX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Crescent Capital Bdc, Inc.?

Key financial highlights from Crescent Capital Bdc, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for FCRX?

The investment thesis for FCRX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Crescent Capital Bdc, Inc.?

Executive information for Crescent Capital Bdc, Inc. is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Crescent Capital Bdc, Inc. stock?

Of FCRX's 15 assessed filings, 2 were flagged high-risk, 3 medium-risk, and 10 low-risk.

What are recent predictions and forward guidance from Crescent Capital Bdc, Inc.?

Forward guidance and predictions for Crescent Capital Bdc, Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.